SCHEMBL3930639

SCHEMBL3930639

O=C(O)c1ccc2ccc3cccnc3c2n1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.66
LMNA P02545 5/20 0.66
KMT2A Q03164 2/20 0.66
MEN1 O00255 1/20 0.66
MMP2 P08253 6/20 0.59
TSHR P16473 3/20 0.59
TDP1 Q9NUW8 3/20 0.59
ALOX15 P16050 2/20 0.59
MAPT P10636 2/20 0.59
HTT P42858 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
GMNN O75496 1/20 0.59
TP53 P04637 1/20 0.59
HSP90AA1 P07900 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
MMP9 P14780 1/20 0.59
NFKB1 P19838 1/20 0.59
MMP8 P22894 1/20 0.59
CCR1 P32246 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL31590844 0.98 KDM4E (0.64) KDM4ELMNAKMT2AMEN1MMP2
Benzene SCHEMBL27872024 0.86 KDM4E (0.70) KDM4ELMNAKMT2AMEN1MMP2
Oxyquinoline SCHEMBL31621298 0.85 KDM4E (0.81) KDM4ELMNAKMT2AMEN1MMP2
Benzene SCHEMBL27888317 0.84 KDM4E (0.68) KDM4ELMNAKMT2AMEN1MMP2
SCHEMBL1088781 0.84 KDM4E (0.67) KDM4ELMNAKMT2AMEN1MMP2
Oxyquinoline SCHEMBL27295916 0.84 KDM4E (0.79) KDM4ELMNAKMT2AMEN1MMP2
SCHEMBL4765306 0.84 LMNA (0.57) KDM4ELMNAKMT2AMEN1MMP2
SCHEMBL12548430 0.84 PIM1 (0.62) KDM4ELMNAKMT2AMEN1MMP2
SCHEMBL810236 0.84 LMNA (0.57) KDM4ELMNAKMT2AMEN1MMP2
SCHEMBL15301492 0.83 CNR2 (0.58) KDM4ELMNAKMT2AMEN1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115317621-A Carbon monoxide and iron chelator targeted combined controllable drug delivery nano-composite medicine system and preparation method thereof 华东理工大学 2022-11-11 CN claimed
CN-112210082-A Europium/copper bimetallic modified zinc coordination polymer material and preparation method and application thereof 浙江师范大学 2021-01-12 CN claimed
WO-2009034235-A1 METHOD OF PROCESSING A CARBOHYDRATE RAW-MATERIAL VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) 2009-03-19 WO claimed
CN-101348502-A 2-benzimidazole-1,10-phenanthroline transient metal complex, and preparation and use thereof CHINESE ACAD INST CHEMISTRY (CN) 2009-01-21 CN claimed
CN-101305002-A Methods of modulating neurotrophin-mediated activity PAINCEPTOR PHARMA CORP (CA) 2008-11-12 CN claimed
CN-114464823-B Oxygen reduction reaction catalyst and preparation method thereof 先进能源产业研究院(广州)有限公司 2024-07-05 CN disclosed
CN-114464823-B Oxygen reduction reaction catalyst and preparation method thereof 先进能源产业研究院(广州)有限公司 2024-07-05 CN disclosed
CN-117504921-A Monoatomic carbon nitride photocatalyst and preparation method and application thereof 北京工业大学 2024-02-06 CN disclosed
EP-4178797-A1 LAMINATED GLASS WITH ANTI-COUNTERFEITING PROPERTIES Kuraray Europe GmbH (DE) 2023-05-17 EP disclosed
CN-116082332-A Method for preparing 2-benzoyl-1, 10-phenanthroline 爱斯特(成都)生物制药股份有限公司 2023-05-09 CN disclosed
CN-115919874-A Application of salicylic acid-phenanthroline copper (II) complex in preparation of medicine for treating liver cancer 江汉大学 2023-04-07 CN disclosed
CN-115569411-A Mineral oil defoaming agent and preparation method thereof 广东中联邦精细化工有限公司 2023-01-06 CN disclosed
EP-0588225-B1 Process for the preparation of aldehydes BASF AG (DE) 1997-06-18 EP disclosed
US-5637311-A ANTIVIRAL AGENTS AND/OR ANTIINFLAMMATORY AGENTS PROCYTE CORPORATION (US) 1997-06-10 US disclosed
EP-0750602-A1 PROCESS FOR PRODUCING ALCOHOLS AND/OR ALDEHYDES BASF AKTIENGESELLSCHAFT (DE) 1997-01-02 EP disclosed
WO-1995025080-A1 PROCESS FOR PRODUCING ALCOHOLS AND/OR ALDEHYDES BASF AKTIENGESELLSCHAFT (DE) 1995-09-21 WO disclosed
US-5387719-A Preparation of aldehydes BASF AKTIENGESELLSCHAFT (DE) 1995-02-07 US disclosed
EP-0588225-A2 Process for the preparation of aldehydes BASF Aktiengesellschaft (DE) 1994-03-23 EP disclosed
EP-0354847-A2 Multiple fluorescence labelling with europium chelators CYBERFLUOR INC. (CA) 1990-02-14 EP disclosed
EP-0027904-A1 Phenanthroline-9-carboxylic acid derivatives, process for their production and pharmaceutical compositions containing them SANDOZ AG (CH) 1981-05-06 EP disclosed